D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
Booking.com
BKNG
|
+$470M |
| 3 |
Qualcomm
QCOM
|
+$398M |
| 4 |
Chevron
CVX
|
+$268M |
| 5 |
Meta Platforms (Facebook)
META
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$914M |
| 2 |
Netflix
NFLX
|
+$305M |
| 3 |
Johnson & Johnson
JNJ
|
+$244M |
| 4 |
McDonald's
MCD
|
+$241M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.56% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 10.21% |
| 4 | Financials | 8.66% |
| 5 | Industrials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
2776
DELISTED
Esperion Therapeutics
ESPR
| $790K | ﹤0.01% |
+17,797
| New | +$817K |
|
2777
PUT
Nexstar Media Group
NXST
$5.72B
| $790K | ﹤0.01% |
9,700
+2,400
| +33% | +$189K |
|
2778
Valero Energy
VLO
$89.9B
| $790K | ﹤0.01% |
6,944
-27,783
| -80% | -$3.16M |
|
2779
TransAlta
TAC
$4.21B
| $787K | ﹤0.01% |
139,700
+64,200
| +85% | +$358K |
|
|
RDUS
2780
CALL
DELISTED
Radius Health, Inc.
RDUS
| $787K | ﹤0.01% |
44,200
+20,000
| +83% | +$452K |
|
2781
InflaRx
IFRX
$253M
| $786K | ﹤0.01% |
22,910
-2,750
| -11% | -$88.7K |
|
2782
Republic Services
RSG
$67.3B
| $785K | ﹤0.01% |
10,800
-7,595
| -41% | -$550K |
|
2783
CALL
Avis
CAR
$5.69B
| $784K | ﹤0.01% |
24,400
+17,100
| +234% | +$570K |
|
2784
Equifax
EFX
$21.1B
| $783K | ﹤0.01% |
5,994
-292,631
| -98% | -$38.1M |
|
2785
Korn Ferry
KFY
$4.13B
| $781K | ﹤0.01% |
15,870
+778
| +5% | +$47.9K |
|
2786
PUT
Shake Shack
SHAK
$2.47B
| $781K | ﹤0.01% |
12,400
+7,000
| +130% | +$425K |
|
2787
PUT
Pitney Bowes
PBI
$2.46B
| $779K | ﹤0.01% |
110,000
+75,000
| +214% | +$606K |
|
2788
Ameresco
AMRC
$1.11B
| $777K | ﹤0.01% |
56,891
-45,917
| -45% | -$627K |
|
|
CIVI
2789
DELISTED
Civitas Resources
CIVI
| $777K | ﹤0.01% |
26,086
-9,195
| -26% | -$307K |
|
2790
PUT
Ingredion
INGR
$6.4B
| $777K | ﹤0.01% |
7,400
-100
| -1% | -$10.2K |
|
2791
CALL
TTEC Holdings
TTEC
$108M
| $777K | ﹤0.01% |
+30,000
| New | +$873K |
|
|
HT
2792
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $776K | ﹤0.01% |
34,223
-53,522
| -61% | -$1.2M |
|
|
KEG
2793
DELISTED
Key Energy Services, Inc. Common Stock
KEG
| $776K | ﹤0.01% |
67,795
+51,141
| +307% | +$747K |
|
|
DQ
2794
PUT
Daqo New Energy
DQ
$816M
| $775K | ﹤0.01% |
+148,500
| New | +$1.04M |
|
2795
Weis Markets
WMK
$1.85B
| $770K | ﹤0.01% |
17,746
+13,461
| +314% | +$654K |
|
|
NAV
2796
CALL
DELISTED
Navistar International
NAV
| $770K | ﹤0.01% |
20,000
| – | – |
|
|
CCRN
2797
DELISTED
Cross Country Healthcare
CCRN
| $769K | ﹤0.01% |
88,058
-6,589
| -7% | -$67.3K |
|
2798
CALL
Alexandria Real Estate Equities
ARE
$9B
| $767K | ﹤0.01% |
6,100
| – | – |
|
|
GBT
2799
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $766K | ﹤0.01% |
+20,150
| New | +$893K |
|
2800
Alnylam Pharmaceuticals
ALNY
$37.6B
| $765K | ﹤0.01% |
8,738
-74,873
| -90% | -$7.53M |
|
Similar funds
D.E. Shaw & Co's Q3 2018 Portfolio in Review
As of Q3 2018, D.E. Shaw & Co held 4,167 positions worth $83.2B, up 8.6% from $76.7B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q3 2018 filing shows 494 new, 1,413 increased, 1,463 reduced and 484 closed positions. Its largest new stake was Six Flags Entertainment Corp.: 850,069 shares worth $59.4M. The largest sale was Apple, an estimated $914M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2018 buy was Six Flags Entertainment Corp.: 850,069 shares worth $59.4M.
- D.E. Shaw & Co added most to AT&T in Q3 2018, an estimated $501M increase.
- D.E. Shaw & Co's biggest Q3 2018 reduction was Apple, cutting an estimated $914M.
- D.E. Shaw & Co fully exited RH in Q3 2018, selling an estimated $43.2M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $83.2B portfolio in Q3 2018.
- D.E. Shaw & Co opened 494 new positions and closed 484 in Q3 2018.
- D.E. Shaw & Co's portfolio value rose 8.6% quarter-over-quarter to $83.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2018, filed 14 Nov 2018.